Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Cytosolic DNA Sensing in Organismal Tumor Control.

Vanpouille-Box C, Demaria S, Formenti SC, Galluzzi L.

Cancer Cell. 2018 Sep 10;34(3):361-378. doi: 10.1016/j.ccell.2018.05.013. Epub 2018 Jun 28. Review.

PMID:
30216189
2.

Percutaneous Cryoablation for the Management of Chronic Pain Secondary to Locally Recurrent Rectal Cancer with Bowel and Nerve Root Involvement.

Cornman-Homonoff J, Formenti SC, Chachoua A, Madoff DC.

J Vasc Interv Radiol. 2018 Sep;29(9):1296-1298. doi: 10.1016/j.jvir.2018.02.022. No abstract available.

PMID:
30146202
3.

Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.

Rodríguez-Ruiz ME, Vanpouille-Box C, Melero I, Formenti SC, Demaria S.

Trends Immunol. 2018 Aug;39(8):644-655. doi: 10.1016/j.it.2018.06.001. Epub 2018 Jul 11. Review.

PMID:
30001871
4.

The Integration of Radiotherapy with Immunotherapy for the Treatment of Non-Small Cell Lung Cancer.

Ko EC, Raben D, Formenti SC.

Clin Cancer Res. 2018 Jun 26. doi: 10.1158/1078-0432.CCR-17-3620. [Epub ahead of print] Review.

PMID:
29945993
5.

Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.

Durante M, Formenti SC.

Front Oncol. 2018 May 29;8:192. doi: 10.3389/fonc.2018.00192. eCollection 2018. Review.

6.

Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs.

Diamond JM, Vanpouille-Box C, Spada S, Rudqvist NP, Chapman JR, Ueberheide BM, Pilones KA, Sarfraz Y, Formenti SC, Demaria S.

Cancer Immunol Res. 2018 Aug;6(8):910-920. doi: 10.1158/2326-6066.CIR-17-0581. Epub 2018 Jun 15.

PMID:
29907693
7.

Understanding Responses to Stereotactic Body Radiotherapy and Pembrolizumab.

Formenti SC, Demaria S.

J Clin Oncol. 2018 Sep 1;36(25):2661-2662. doi: 10.1200/JCO.2018.78.7622. Epub 2018 Jun 5. No abstract available.

PMID:
29870291
8.

Hypofractionated Whole-Breast Irradiation in Women Less Than 50 Years Old Treated on 4 Prospective Protocols.

Shaikh F, Chew J, Hochman T, Purswani J, Maisonet O, Peat E, Huppert N, Cooper BT, Tam M, Goldberg JD, Perez CA, Formenti SC, Gerber NK.

Int J Radiat Oncol Biol Phys. 2018 Aug 1;101(5):1159-1167. doi: 10.1016/j.ijrobp.2018.04.034. Epub 2018 Apr 19.

PMID:
29859789
9.

Workshop Report for Cancer Research: Defining the Shades of Gy: Utilizing the Biological Consequences of Radiotherapy in the Development of New Treatment Approaches-Meeting Viewpoint.

Ahmed MM, Coleman CN, Mendonca M, Bentzen S, Vikram B, Seltzer SM, Goodhead D, Obcemea C, Mohan R, Prise KM, Capala J, Citrin D, Kao G, Aryankalayil M, Eke I, Buchsbaum JC, Prasanna PGS, Liu FF, Le QT, Teicher B, Kirsch DG, Smart D, Tepper J, Formenti S, Haas-Kogan D, Raben D, Mitchell J.

Cancer Res. 2018 May 1;78(9):2166-2170. doi: 10.1158/0008-5472.CAN-17-3760. Epub 2018 Apr 23. No abstract available.

PMID:
29686020
10.

Radiotherapy and checkpoint inhibitors: a winning new combination?

Ko EC, Formenti SC.

Ther Adv Med Oncol. 2018 Apr 11;10:1758835918768240. doi: 10.1177/1758835918768240. eCollection 2018. Review.

11.

Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores.

Chen J, Wu X, Christos PJ, Formenti S, Nagar H.

Breast Cancer Res. 2018 Apr 16;20(1):26. doi: 10.1186/s13058-018-0957-3.

12.

Dual Transforming Growth Factor-β and Programmed Death-1 Blockade: A Strategy for Immune-Excluded Tumors?

Vanpouille-Box C, Formenti SC.

Trends Immunol. 2018 Jun;39(6):435-437. doi: 10.1016/j.it.2018.03.002. Epub 2018 Mar 26.

PMID:
29598848
14.

PTEN at the interface of immune tolerance and tumor suppression.

Brandmaier A, Hou SQ, Demaria S, Formenti SC, Shen WH.

Front Biol (Beijing). 2017 Jun;12(3):163-174. doi: 10.1007/s11515-017-1443-5. Epub 2017 Mar 4.

15.
16.

Qualitative Assessment of Academic Radiation Oncology Department Chairs' Insights on Diversity, Equity, and Inclusion: Progress, Challenges, and Future Aspirations.

Jones RD, Chapman CH, Holliday EB, Lalani N, Wilson E, Bonner JA, Movsas B, Kalnicki S, Formenti SC, Thomas CR Jr, Hahn SM, Liu FF, Jagsi R; Society of Chairs of Academic Radiation Oncology Programs (SCAROP).

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):30-45. doi: 10.1016/j.ijrobp.2018.01.012. Epub 2018 Jan 9.

PMID:
29477292
17.

Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer.

Formenti SC, Lee P, Adams S, Goldberg JD, Li X, Xie MW, Ratikan JA, Felix C, Hwang L, Faull KF, Sayre JW, Hurvitz S, Glaspy JA, Comin-Anduix B, Demaria S, Schaue D, McBride WH.

Clin Cancer Res. 2018 Jun 1;24(11):2493-2504. doi: 10.1158/1078-0432.CCR-17-3322. Epub 2018 Feb 23.

PMID:
29476019
18.

Using immunotherapy to boost the abscopal effect.

Ngwa W, Irabor OC, Schoenfeld JD, Hesser J, Demaria S, Formenti SC.

Nat Rev Cancer. 2018 May;18(5):313-322. doi: 10.1038/nrc.2018.6. Epub 2018 Feb 16. Review.

19.

Optimizing Dose Per Fraction: A New Chapter in the Story of the Abscopal Effect?

Formenti SC.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):677-679. doi: 10.1016/j.ijrobp.2017.07.028. No abstract available.

PMID:
29280462
20.

Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.

Lhuillier C, Vanpouille-Box C, Galluzzi L, Formenti SC, Demaria S.

Semin Cancer Biol. 2018 Oct;52(Pt 2):125-134. doi: 10.1016/j.semcancer.2017.12.007. Epub 2017 Dec 16. Review.

PMID:
29258856
21.

Integration of radiation and immunotherapy in breast cancer - Treatment implications.

Ye JC, Formenti SC.

Breast. 2018 Apr;38:66-74. doi: 10.1016/j.breast.2017.12.005. Epub 2018 Jan 4. Review.

PMID:
29253718
22.

Metastatic Osseous Pain Control: Radiation Therapy.

Kang J, Formenti SC.

Semin Intervent Radiol. 2017 Dec;34(4):322-327. doi: 10.1055/s-0037-1608703. Epub 2017 Dec 14. Review.

PMID:
29249855
23.

Radiotherapy and CTLA-4 Blockade Shape the TCR Repertoire of Tumor-Infiltrating T Cells.

Rudqvist NP, Pilones KA, Lhuillier C, Wennerberg E, Sidhom JW, Emerson RO, Robins HS, Schneck J, Formenti SC, Demaria S.

Cancer Immunol Res. 2018 Feb;6(2):139-150. doi: 10.1158/2326-6066.CIR-17-0134. Epub 2017 Nov 27.

PMID:
29180535
24.

Trial watch: Immune checkpoint blockers for cancer therapy.

Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2017 Aug 31;6(11):e1373237. doi: 10.1080/2162402X.2017.1373237. eCollection 2017. Review.

25.

Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.

Ascierto PA, Agarwala SS, Ciliberto G, Demaria S, Dummer R, Duong CPM, Ferrone S, Formenti SC, Garbe C, Halaban R, Khleif S, Luke JJ, Mir LM, Overwijk WW, Postow M, Puzanov I, Sondel P, Taube JM, Thor Straten P, Stroncek DF, Wargo JA, Zarour H, Thurin M.

J Transl Med. 2017 Nov 16;15(1):236. doi: 10.1186/s12967-017-1341-2.

26.

TREX1 dictates the immune fate of irradiated cancer cells.

Vanpouille-Box C, Formenti SC, Demaria S.

Oncoimmunology. 2017 Jun 16;6(9):e1339857. doi: 10.1080/2162402X.2017.1339857. eCollection 2017.

27.

Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs.

Holliday EB, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Fuller CD, Thomas CR Jr.

J Healthc Manag. 2017 Sep/Oct;62(5):302-313. doi: 10.1097/JHM-D-16-00001.

PMID:
28885530
28.

In Regard to Rahimi et al.

Gerber NK, Formenti SC.

Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):498-499. doi: 10.1016/j.ijrobp.2017.05.047. No abstract available.

PMID:
28872002
29.

Toward Precision Radiotherapy for Use with Immune Checkpoint Blockers.

Vanpouille-Box C, Formenti SC, Demaria S.

Clin Cancer Res. 2018 Jan 15;24(2):259-265. doi: 10.1158/1078-0432.CCR-16-0037. Epub 2017 Jul 27. Review.

PMID:
28751442
30.

Preplanning prediction of the left anterior descending artery maximum dose based on patient, dosimetric, and treatment planning parameters.

Cooper BT, Li X, Shin SM, Modrek AS, Hsu HC, DeWyngaert JK, Jozsef G, Lymberis SC, Goldberg JD, Formenti SC.

Adv Radiat Oncol. 2016 Aug 9;1(4):373-381. doi: 10.1016/j.adro.2016.08.001. eCollection 2016 Oct-Dec.

31.

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

Vanpouille-Box C, Alard A, Aryankalayil MJ, Sarfraz Y, Diamond JM, Schneider RJ, Inghirami G, Coleman CN, Formenti SC, Demaria S.

Nat Commun. 2017 Jun 9;8:15618. doi: 10.1038/ncomms15618.

32.

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial.

Shaverdian N, Lisberg AE, Bornazyan K, Veruttipong D, Goldman JW, Formenti SC, Garon EB, Lee P.

Lancet Oncol. 2017 Jul;18(7):895-903. doi: 10.1016/S1470-2045(17)30380-7. Epub 2017 May 24. Erratum in: Lancet Oncol. 2017 Jul;18(7):e371.

33.

Results of a phase I-II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer.

Formenti SC, Golden EB, Goldberg JD, Li X, Taff J, Fenton-Kerimian MB, Chandrasekhar S, Demaria S, Novik Y.

Oncoimmunology. 2016 Dec 27;6(3):e1274479. doi: 10.1080/2162402X.2016.1274479. eCollection 2017.

34.

Barriers to Radiation-Induced In Situ Tumor Vaccination.

Wennerberg E, Lhuillier C, Vanpouille-Box C, Pilones KA, García-Martínez E, Rudqvist NP, Formenti SC, Demaria S.

Front Immunol. 2017 Mar 13;8:229. doi: 10.3389/fimmu.2017.00229. eCollection 2017. Review.

35.

Smart Radiation Therapy Biomaterials.

Ngwa W, Boateng F, Kumar R, Irvine DJ, Formenti S, Ngoma T, Herskind C, Veldwijk MR, Hildenbrand GL, Hausmann M, Wenz F, Hesser J.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):624-637. doi: 10.1016/j.ijrobp.2016.10.034. Epub 2016 Nov 1. Review.

36.

Does Heavy Ion Therapy Work Through the Immune System?

Durante M, Brenner DJ, Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):934-936. doi: 10.1016/j.ijrobp.2016.08.037. Epub 2016 Sep 5. No abstract available.

PMID:
27869095
37.

Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.

Galluzzi L, Bravo-San Pedro JM, Demaria S, Formenti SC, Kroemer G.

Nat Rev Clin Oncol. 2017 Apr;14(4):247-258. doi: 10.1038/nrclinonc.2016.183. Epub 2016 Nov 15. Review.

PMID:
27845767
38.

Radiotherapy: Changing the Game in Immunotherapy.

Demaria S, Coleman CN, Formenti SC.

Trends Cancer. 2016 Jun;2(6):286-294. Review.

39.

Trial Watch: Immunotherapy plus radiation therapy for oncological indications.

Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2016 Jul 25;5(9):e1214790. eCollection 2016. Review.

40.

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Eggermont A, Tartour E, Johannes L, Woerther PL, Chachaty E, Soria JC, Golden E, Formenti S, Plebanski M, Madondo M, Rosenstiel P, Raoult D, Cattoir V, Boneca IG, Chamaillard M, Zitvogel L.

Immunity. 2016 Oct 18;45(4):931-943. doi: 10.1016/j.immuni.2016.09.009. Epub 2016 Oct 4.

41.

Current clinical trials testing the combination of immunotherapy with radiotherapy.

Kang J, Demaria S, Formenti S.

J Immunother Cancer. 2016 Sep 20;4:51. doi: 10.1186/s40425-016-0156-7. eCollection 2016.

42.

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure.

Katz A, Formenti SC, Kang J.

Front Oncol. 2016 Jul 8;6:168. doi: 10.3389/fonc.2016.00168. eCollection 2016.

43.

The Pace of Progress in Radiation and Immunotherapy.

Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1257-8. doi: 10.1016/j.ijrobp.2016.02.063. No abstract available.

PMID:
27354133
44.

Can abscopal effects of local radiotherapy be predicted by modeling T cell trafficking?

Demaria S, Formenti SC.

J Immunother Cancer. 2016 May 17;4:29. doi: 10.1186/s40425-016-0133-1. eCollection 2016.

45.

Prospective Randomized Trial of Prone Accelerated Intensity Modulated Breast Radiation Therapy With a Daily Versus Weekly Boost to the Tumor Bed.

Cooper BT, Formenti-Ujlaki GF, Li X, Shin SM, Fenton-Kerimian M, Guth A, Roses DF, Hitchen CJ, Rosenstein BS, Dewyngaert JK, Goldberg JD, Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):571-8. doi: 10.1016/j.ijrobp.2015.12.373. Epub 2015 Dec 29.

PMID:
27131077
46.

Silvia Formenti on the promise of combining radiotherapy and immunotherapy to treat cancer.

Formenti SC.

Oncology (Williston Park). 2016 Apr;30(4):289, 292. No abstract available.

47.

Quality of Life in Women Undergoing Breast Irradiation in a Randomized, Controlled Clinical Trial Evaluating Different Tumor Bed Boost Fractionations.

Finkel MA, Cooper BT, Li X, Fenton-Kerimian M, Goldberg JD, Formenti SC.

Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):579-89. doi: 10.1016/j.ijrobp.2016.02.004. Epub 2016 Feb 6.

PMID:
27045811
48.

Subverting misconceptions about radiation therapy.

Formenti SC, Demaria S, Barcellos-Hoff MH, McBride WH.

Nat Immunol. 2016 Apr;17(4):345. doi: 10.1038/ni.3363. No abstract available.

PMID:
27002831
49.

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials.

Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, Lyerly HK, Maecker H, Marabelle A, Melenhorst J, Miller J, Melero I, Odunsi K, Palucka K, Peoples G, Ribas A, Robins H, Robinson W, Serafini T, Sondel P, Vivier E, Weber J, Wolchok J, Zitvogel L, Disis ML, Cheever MA; Cancer Immunotherapy Trials Network (CITN).

J Immunother Cancer. 2016 Mar 15;4:15. doi: 10.1186/s40425-016-0118-0. eCollection 2016. Review.

50.

Cesium-131 brachytherapy in high risk and recurrent head and neck cancers: first report of long-term outcomes.

Pham A, Arora S, Wernicke AG, Kutler DI, Cohen M, Kuhel W, Trichter S, Nori D, Formenti SC, Parashar B.

J Contemp Brachytherapy. 2015 Dec;7(6):445-52. doi: 10.5114/jcb.2015.56764. Epub 2015 Dec 30.

Supplemental Content

Loading ...
Support Center